BAUDAX BIO INC's ticker is BXRX and the CUSIP is 07160F107. A total of 34 filers reported holding BAUDAX BIO INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $800,000 | -62.1% | 3,650,976 | -2.4% | 0.00% | – |
| Q3 2021 | $2,109,000 | -25.6% | 3,740,262 | +0.3% | 0.00% | – |
| Q2 2021 | $2,836,000 | -43.5% | 3,727,800 | -4.1% | 0.00% | – |
| Q1 2021 | $5,016,000 | +903.2% | 3,888,260 | +685.2% | 0.00% | – |
| Q4 2020 | $500,000 | -52.7% | 495,206 | +29.9% | 0.00% | – |
| Q3 2020 | $1,056,000 | -32.7% | 381,222 | +0.9% | 0.00% | – |
| Q2 2020 | $1,568,000 | +52.4% | 377,851 | -9.0% | 0.00% | – |
| Q1 2020 | $1,029,000 | -60.8% | 415,250 | +9.6% | 0.00% | – |
| Q4 2019 | $2,623,000 | – | 378,957 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 1,152,539 | $4,783,000 | 6.56% |
| Corsair Capital Management | 870,123 | $3,611,000 | 1.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 157,220 | $652,000 | 0.26% |
| Leap Investments LP | 19,000 | $79,000 | 0.05% |
| Alyeska Investment Group, L.P. | 815,384 | $3,384,000 | 0.05% |
| Ikarian Capital, LLC | 100,000 | $415,000 | 0.03% |
| Brandywine Global Investment Management, LLC | 187,252 | $778,000 | 0.01% |
| OLD MISSION CAPITAL LLC | 19,600 | $81,000 | 0.01% |
| Verition Fund Management LLC | 27,000 | $112,000 | 0.00% |
| Paloma Partners Management Co | 48,744 | $202,000 | 0.00% |